Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Antidiabetic effect of A2B adenosine receptor antagonism

Sep. 28, 2005

Lipitor approved to reduce risk of strokes and heart attacks in diabetics

Sep. 28, 2005

A novel glucokinase activator shows promise as an antidiabetic

Sep. 28, 2005

Novel peptide from shark liver exerts antidiabetic effects in mice

Sep. 28, 2005

Good PK profile reported for AMG-162 in postmenopausal women

Sep. 27, 2005

Sildenafil and testosterone work synergistically in hypogonadal men

Sep. 27, 2005

DPP-IV inhibition does not affect physiological tissue microcirculation

Sep. 27, 2005

BVT-2733 improves energy balance and glucose homeostasis in diet-induced obesity

Sep. 27, 2005

FK-614 improves insulin sensitivity both in the liver and in peripheral tissues

Sep. 27, 2005

TGF-beta signaling pathways implicated in liraglutide's efficacy for type 2 diabetes

Sep. 27, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...